Urine amino and organic acids analysis in developmental delay or intellectual disability

Journal of Paediatrics and Child Health

Volumn 38, Issue 5, 2002, Pages 475-480

  Poplawski, N K ^a   Harrison, J R ^a   Norton, W ^a   Wiltshire, E ^a   Fletcher, J M ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Amino acids; Developmental disabilities; Inborn errors; Metabolism; Organic acids

Indexed keywords

AMINO ACID; CARBOXYLIC ACID; OROTIC ACID; TRIMETHYLAMINE;

ADOLESCENT; ADULT; AGED; AMINO ACID ANALYSIS; ARTICLE; CHILD; COLORIMETRY; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INFANT; INHERITANCE; INTELLECTUAL IMPAIRMENT; ION EXCHANGE CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEDICAL DECISION MAKING; NEWBORN; PRIORITY JOURNAL; SCREENING; URINALYSIS;

AMINO ACIDS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, ION EXCHANGE; DEVELOPMENTAL DISABILITIES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT; MALE; MENTAL RETARDATION; OROTIC ACID; RETROSPECTIVE STUDIES;

EID: 0036405611     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2002.00032.x     Document Type: Article

References (26)

1. Battaglia A, Bianchini E, Carey JC. Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neuropsychiatry. Am. J. Med. Genet. 1999; 82: 60-66.
2. Roeleveld N, Zielhuis GA, Gabreëls F. The prevalence of mental retardation: a critical review of recent literature. Dev. Med. Child. Neurol. 1997; 39: 125-32.
3. Schaefer GB, Bodensteiner JB. Evaluation of the child with idiopathic mental retardation. Pediatr. Clin. North Am. 1992; 39: 929-43.
4. Yeargin-Allsopp M, Murphy CC, Oakley GP, Sikes RK, Metropolitan Atlanta Developmental Disabilities Study Staff. A multiple-source method for studying the prevalence of developmental disabilities in children: the Metropolitan Atlanta Developmental Disabilities Study. Pediatrics 1992; 89: 624-30.
5. Kraus J. Prevalence of intellectual deficiency in New South Wales. Med. J. Aust. 1973; 1: 795-7.
6. McLaren J, Bryson SE. Review of recent epidemiological studies of mental retardation: prevalence, associated disorders and etiology. Am. J. Ment. Retard. 1987; 92: 243-54.
7. Curry CJ, Stevenson RE, Aughton D et al. Evaluation of mental retardation: recommendations of a consensus conference. Am. J. Med. Genet. 1997; 72: 468-77.
8. Palfrey JS. Determining the etiology of developmental delay in very young children: What if we had a common internationally accepted protocol?!. J. Pediatr. 2000; 136: 569-70.
9. Hunter AG. Outcome of the routine assessment of patients with mental retardation in a genetics clinic. Am. J. Med. Genet. 2000; 90: 60-68.
10. Stromme P, Hagberg G. Aetiology in severe and mild mental retardation. a population-based study of Norwegian children. Dev. Med. Child. Neurol. 2000; 42: 76-86.
11. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of subspecialists' evaluation of young children with global developmental delay. J. Pediatr. 2000; 136: 593-8.
12. Gonzalez-del Angel A, Vidal S, Saldaña Y et al. Molecular diagnosis of the fragile X and FRAXE syndromes in patients with mental retardation of unknown cause in Mexico. Ann. Génét. 2000; 43: 29-34.
13. White BJ, Ayad M, Fraser A et al. A 6-year experience demonstrates the utility of screening for both cytogenetic and FMR-1 abnormalities in patients with mental retardation. Genet. Test. 1999; 3: 291-6.
14. Gérard B, le Heuzey MF, Brunie G et al. Systematic screening for fragile X syndrome in a cohort of 574 mentally retarded children. Ann. Génét. 1997; 40: 139-44.
15. Majnemer A, Shevell MI. Diagnostic yield of the neurologic assessment of the developmentally delayed child. J. Pediatr. 1995; 127: 193-9.
16. Kaplan G, Kung M, McClure M, Cronister A. Direct mutation analysis of 495 patients for fragile X carrier status/proband diagnosis. Am. J. Med. Genet. 1994; 51: 501-2.
17. Demaerel P, Kingsley DP, Kendall BE. Isolated neurodevelopmental delay in childhood: clinicoradiological correlation in 170 patients. Pediatr. Radiol. 1993; 23: 29-33.
18. Graham SM, Selikowitz M. Chromosome testing in children with developmental delay in whom the aetiology is not evident. J. Paediatr. Child Health 1993; 29: 360-62.
19. Roth KS. Inborn errors of metabolism: The essentials of clinical diagnosis. Clin. Pediatr. 1991; 30: 183-90.
20. Goldstein AS, Hoogenraad NJ, Johnson JD et al. Metabolic and genetic studies of a family with ornithine transcarbamylase deficiency. Pediatr. Res. 1974; 8: 5-12.
21. Treacy EP, Akerman BR, Chow LM et al. Mutations of the flavin-containing monooxygenase gene (FMO3) causes trimethylaminuria, a defect in detoxication. Hum. Mol. Genet. 1998; 7: 839-45.
22. Poplawski NK, Ranieri E, Harrison JR, Fletcher JM. Multiple acyl-coenzyme A dehydrogenase deficiency. Diagnosis by acyl-carnitine analysis of a 12-year-old newborn screening card. J. Pediatr. 1999; 134: 764-6.
23. Sniderman LC, Lambert M, Giguère R et al. Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J. Pediatr. 1999; 134: 675-80.
24. Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Colombia, 1969-96. Pediatrics [serial online] 2000 [cited 3 August 2000]; 105(1): E10. Available from: URL: http://www.pediatrics.org/cgi/content/full/105/1/e10.pdf
25. Department of Health and Aged Care, Health Access and Financing Division. Medical Benefits Schedule, 1 November 2000. [cited 8 April 2001] Available from: URL: http://www.health.gov.au/pubs/mbs/mbs6/default.htm
26. Carpenter K, Wiley V, Sim KG, Heath D, Wilcken B. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch. Dis. Child. Fetal Neonatal Ed. 2001; 85: F105-F109.